Evidence map›Paper›PMID 41582646›Full record

ArticleActa anaesthesiologica Scandinavica2026

Pain Management in Aneurysmatic Subarachnoid Haemorrhage: A Survey of Nordic Physicians.

Hanna Sariola, Maija-Liisa Kalliomäki, Heikki Kiiski, Essi Raatikainen, Juhana Frösen, Matti Reinikainen, Hanna Savioja, Kirsten Møller, Terhi Lohela, Riikka Takala and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hanna SariolaDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.ORCID 0009-0002-4436-7173
Maija-Liisa KalliomäkiDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.ORCID 0000-0002-6501-8928
Heikki KiiskiDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.
Essi RaatikainenDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.
Juhana FrösenDepartment of Neurosurgery, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.
Matti ReinikainenDepartment of Anaesthesiology and Intensive Care, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Hanna SaviojaDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.
Kirsten MøllerDepartment of Neuroanaesthesiology, Neuroscience Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-3058-1072
Terhi LohelaIndividualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Riikka TakalaPerioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, Turku, Finland.
Martin SigurdssonDepartment of Anaesthesiology and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavík, Iceland.
Luis RomundstadDepartment of Anaesthesia and Intensive Care Medicine, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Stig DyrskogDepartment of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
Karsten BülowDepartment of Anaesthesiology and Intensive Care, Odense University Hospital, Odense, Denmark.
Johanna HästbackaDepartment of Anaesthesiology and Intensive Care, Wellbeing Services County of Pirkanmaa, Tampere University Hospital and Tampere University, Tampere, Finland.

Funding

State funding for university-level health research, Tampere University Hospital, Wellbeing services county of Pirkanmaa T63804Suomen Anestesiologiyhdistys
6 · The paper itself

Abstract

backgroundHeadache caused by aneurysmatic subarachnoid hemorrhage (aSAH) is often severe and may persist long after the ictus. Pharmacological pain management can be challenging due to poor efficacy or adverse effects. Multimodal pharmacotherapy is often required. Lack of guidelines and good quality clinical studies on pain management has led to variation in pain management practices. Knowledge of current practice and goals of pain management in Nordic countries is lacking. We aimed to fill these knowledge gaps by conducting a survey targeting Nordic clinicians involved in aSAH treatment.

methodsAn electronic survey in English was sent to national coordinators in December 2023. The coordinators distributed the survey to intensivists, neurosurgeons, and other specialists treating aSAH patients in their respective countries. The survey contained 63 questions gathering background information, current aSAH pain management during the hospital stay and at hospital discharge, follow-up, and preferred outcome measures regarding a clinical trial on pain management in aSAH. The results were analysed and presented descriptively.

resultsWe received 70 responses: 36 from Finland, 11 from Norway, 11 from Denmark, 5 from Sweden and 7 from Iceland. Respondents were intensivists (N = 46), neurosurgeons (N = 20), neurologists (N = 2), and others (N = 2). The most frequently used pain medications at ICUs were paracetamol, opioids, and non-steroidal anti-inflammatory drugs (NSAID). Most neurosurgeons (70%, N = 14) responded that they never prescribe opioids at hospital discharge for aSAH patients. The most preferred outcome for a clinical trial was patients' self-reported quality of life.

conclusionsIn the Nordic countries, paracetamol, opioids, and NSAIDs were reported as the most frequently used analgesics in the management of aSAH related pain in the ICU. Use of gabapentinoids was commonly reported by Danish respondents, unlike respondents from other Nordic countries. Neurosurgeons reported that they rarely prescribe opioids at hospital discharge. EDITORIAL COMMENT: This survey of Nordic clinicians involved in ICU and neurosurgical management of subarachnoid bleed (aneurysm) cases presents preferences for pain management in hospital and with discharge, as well as assessing clinician preferences for outcomes by which to assess pain management in these cases.

Indexed as

Pain ManagementPractice Patterns, Physicians'Subarachnoid HemorrhageHumansPhysiciansScandinavian and Nordic CountriesSurveys and Questionnaires

Identifiers

PMID41582646
PMCPMC12833550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.